BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34808091)

  • 21. Detecting the impacts of humidity, rainfall, temperature, and season on chikungunya, dengue and Zika viruses in Aedes albopictus mosquitoes from selected sites in Cebu city, Philippines.
    Edillo F; Ymbong RR; Navarro AO; Cabahug MM; Saavedra K
    Virol J; 2024 Feb; 21(1):42. PubMed ID: 38360693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Wild Monkeys in Thailand.
    Tongthainan D; Mongkol N; Jiamsomboon K; Suthisawat S; Sanyathitiseree P; Sukmak M; Wajjwalku W; Poovorawan Y; Ieamsaard G; Sangkharak B; Taruyanon K; Fungfuang W; Tulayakul P; Boonnak K
    Am J Trop Med Hyg; 2020 Sep; 103(3):1228-1233. PubMed ID: 32588813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.
    Priyamvada L; Hudson W; Ahmed R; Wrammert J
    Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
    Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
    Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection.
    Balmaseda A; Zambrana JV; Collado D; García N; Saborío S; Elizondo D; Mercado JC; Gonzalez K; Cerpas C; Nuñez A; Corti D; Waggoner JJ; Kuan G; Burger-Calderon R; Harris E
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29305550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Dengue, Chikungunya and Zika at the epicenter of the congenital microcephaly epidemic in Northeast Brazil: A population-based survey.
    Braga C; Martelli CMT; Souza WV; Luna CF; Albuquerque MFPM; Mariz CA; Morais CNL; Brito CAA; Melo CFCA; Lins RD; Drexler JF; Jaenisch T; Marques ETA; Viana IFT
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011270. PubMed ID: 37399197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperendemic Dengue and Possible Zika Circulation in the Westernmost Region of the Indonesian Archipelago.
    Harapan H; Panta K; Michie A; Ernst T; McCarthy S; Muhsin M; Safarianti S; Zanaria TM; Mudatsir M; Sasmono RT; Imrie A
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border.
    Carrillo-Hernández MY; Ruiz-Saenz J; Villamizar LJ; Gómez-Rangel SY; Martínez-Gutierrez M
    BMC Infect Dis; 2018 Jan; 18(1):61. PubMed ID: 29382300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.
    Katzelnick LC; Zambrana JV; Elizondo D; Collado D; Garcia N; Arguello S; Mercado JC; Miranda T; Ampie O; Mercado BL; Narvaez C; Gresh L; Binder RA; Ojeda S; Sanchez N; Plazaola M; Latta K; Schiller A; Coloma J; Carrillo FB; Narvaez F; Halloran ME; Gordon A; Kuan G; Balmaseda A; Harris E
    Sci Transl Med; 2021 Oct; 13(614):eabg9478. PubMed ID: 34613812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of dengue, Japanese encephalitis and Zika among long-term expatriates in Thailand.
    Kitro A; Imad HA; Pisutsan P; Matsee W; Sirikul W; Sapbamrer R; Rapheal E; Fernandez S; Cotrone TS; Farmer AR; Hunsawong T; Silachamroon U; Chatapat L; Olanwijitwong J; Salee P; Anderson KB; Piyaphanee W
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38335250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.
    Maeki T; Tajima S; Ando N; Wakimoto Y; Hayakawa K; Kutsuna S; Kato F; Taniguchi S; Nakayama E; Lim CK; Saijo M
    J Infect Chemother; 2023 May; 29(5):469-474. PubMed ID: 36702208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.
    Calvert AE; Horiuchi K; Boroughs KL; Ong YT; Anderson KM; Biggerstaff BJ; Stone M; Simmons G; Busch MP; Huang CY
    J Clin Microbiol; 2021 Jul; 59(8):e0040021. PubMed ID: 33980647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue Virus and Zika Virus Seroprevalence in the South Pacific Populations of the Cook Islands and Vanuatu.
    Saretzki CEB; Dobler G; Iro E; Heussen N; Küpper T
    Viruses; 2024 May; 16(5):. PubMed ID: 38793688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.